Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy. The BSA-based method of dose calculation was adopted without adequate investigation of its ...

How many of us give a “full” dose of chemotherapy to an obese patient—even in the curative setting? Dose calculation in the obese is a confusing but important puzzle for the oncologist and is becoming ...